share_log

Oramed Pharmaceuticals | 424B5: Prospectus

SEC announcement ·  Sep 1, 2021 08:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more